Upload File

nexavar concepts 1_finalv6

4
Cancer doesn’t fight fair.

Upload: bill-wiles

Post on 17-Aug-2015

21 views

Category:

Documents


0 download

Report

Tags:

TRANSCRIPT

Page 1: nexavar concepts 1_FINALv6

Cancer doesn’t fight fair.

neither do we neither do we

Page 2: nexavar concepts 1_FINALv6

Nexavar continues to deliver on its promise – to patients, to their families, and to those dedicated to treating cancer.

Page 3: nexavar concepts 1_FINALv6

Leading the way in cancer therapy

Extend Life

Page 4: nexavar concepts 1_FINALv6

Kidney 2005

Advanced renal cell carcinoma

A history of support

Liver 2007

Unresectable hepatocellular

carcinoma

Thyroid 2013

Differentiated thyroid carcinoma refractory to

radioactive iodine

NexavarA legacy of survival

Nexavar continues to deliver on its promise – to patients, to their families, and to those

dedicated to treating cancer.

Extend Life


Meeting Clinicians’ and Patients’ Needs in Buclin_Meeting... · Sorafenib Nexavar Bayer, Onyx 2006 Renal cell carcinoma, Hepatocellular carcinoma, Differentiated thyroid carcinoma

NEXAVAR Prescribing Information - Bayer HealthCarelabeling.bayerhealthcare.com/html/products/pi/Nexavar_PI.pdfHIGHLIGHTS OF PRESCRIBING INFORMATION ... HealthCare Pharmaceuticals Inc

neXaVar: the First marKet- initiateD compulsory licencenujslawreview.org/wp-content/uploads/2017/03/2016-9-3-4-Dr_-Feroz... · Nexavar, was the world’s ... Common Sense, Nonsense

Clinical Policy: Sorafenib (Nexavar)€¦ · Clinical Policy: Sorafenib (Nexavar) Reference Number: CP.PHAR.69 Effective Date: 07.01.11 Last Review Date: 05.19 Line of Business: Commercial,

Sorafenib: a multitargeted oral agent for the treatment of …€¦ · Sorafenib: chemistry & preclinical experience Sorafenib (Nexavar®, Bayer Pharmaceuticals Corporation, Leverkusen,

Australian public assessment report for Sorafenib · Web viewAustralian Public Assessment Report for Sorafenib Proprietary Product Name: Nexavar Sponsor: Bayer Australia Ltd About

Nexavar in Patients with Renal Cell Carcinoma

pan-Canadian Oncology Drug Review Initial Clinical ...€¦ · Sorafenib (Nexavar) for Differentiated Thyroid Cancer . April 30, 2015 . DISCLAIMER . Not a Substitute for Professional

See full prescribing information for NEXAVAR....NEXAVAR (sorafenib) tablets, oral Initial U.S. Approval: 2005----- INDICATIONS AND USAGE-----NEXAVAR is a kinase inhibitor indicated

Nexavar 200 mg Sorafenib Tablet

Nexavar - cdn.wikibula.com.brcdn.wikibula.com.br/bulas/pdf/nexavar-bula-bayer-profissional.pdf · A probabilidade de sobrevida em 1 ano foi estimada em 64,9% para o sorafenibe e 57,7%

Clinical Policy: Sorafenib (Nexavar)€¦ · Sorafenib (Nexavar ®) is a kinase inhibitor. FDA Approved Indication(s) Nexavar (sorafenib) is indicated for the treatment of: • Unresectable

Treatment With NEXAVAR (sorafenib)

The Burning Platform ¬ Sorafenib (Nexavar®) € 46,000 ¬ Trastuzumab (Herceptin®) € 38,200 ¬ Bevacizumab (Avastin®) € 37,200 ¬ Imatinib (Glivec 400®) € 36,400 ¬ Erlotinib

Sorafenib, a multikinase inhibitor, induces formation of ...€¦ · Sorafenib (Nexavar®), an Raf1/Mek/Erk kinase inhibitor approved for advanced hepatocarcinoma cells (HCC) [35],

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights … · NEXAVAR is indicated for the treatment of patients with locally recurrent or metastatic, progressive, differentiated

Nexavar : EPAR - Product Information - European Medicines Agency

ANHANG I ZUSAMMENFASSUNG DER MERKMALE …ec.europa.eu/health/documents/community-register/2006/...2 1. BEZEICHNUNG DES ARZNEIMITTELS Nexavar 200 mg Filmtabletten 2. QUALITATIVE UND

Clinical Policy: Sorafenib (Nexavar) - Superior HealthPlan · 2020-06-10 · Sorafenib (Nexavar ®) is a kinase inhibitor. FDA Approved Indication(s) Nexavar (sorafenib) is indicated

5.01.591 Immune Checkpoint Inhibitors - Premera Blue CrossAug 01, 2020  · Nexavar® (sorafenib) • Adult and pediatric patients with recurrent locally advanced or metastatic Merkel

PRODUCT MONOGRAPH - Bayeromr.bayer.ca/omr/online/nexavar-pm-en.pdf · NEXAVAR Product Monograph Page 1of 57 PRODUCT MONOGRAPH ... reported in some patients taking warfarin while on

AusPAR Attachment 1: Product information for Nexavar · 2014-10-06 · Attachment 1: Product information for AusPAR Nexavar Sorafenib Bayer Australia Ltd PM -2013-02057-1-4 Final

Nexavar, INN-Sorafenib

Cancer diseases – NEXAVAR Identifying genuine products of ... · 1. Blue Box Europe only: on the back of the Nexavar® folding box is a blue frame (blue box) which may contain (varying)

Evaluation of sorafenib for advanced hepatocellular carcinoma … · Sorafenib (Nexavar; Bayer Healthcare, Leverkusen, Ger-many) is an oral multi-targeted tyrosine kinase inhibitor

Indian Sorafenib Tablet Price Nexavar Alternative Sorafenat Natco Online

Nexavar - ema.europa.eu...sorafenib and therefore the warning that there is limited experience with the use of Nexavar in elderly in was deleted from the SmPC. II/0032 Update of SmPC

ANHANG I ZUSAMMENFASSUNG DER MERKMALE … · 2 1. BEZEICHNUNG DES ARZNEIMITTELS. Nexavar 200 mg Filmtabletten . 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG. Jede Filmtablette

Concepts Concepts ArchitecturauxArchitecturaux ......Concepts Concepts ArchitecturauxArchitecturaux Architectural Concepts Artydis / Goodwood Hôpital Privé - Villeneuve d’Ascq

Clinical Policy: Sorafenib (Nexavar) · 2020-04-30 · Clinical Policy: Sorafenib (Nexavar) Reference Number: CP.PHAR.69 Effective Date: 07.01.11 Last Review Date: 05.19 Line of Business:

ANHANG I ZUSAMMENFASSUNG DER MERKMALE …...Nexavar 200 mg Filmtabletten 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG Jede Filmtablette enthält 200 mg Sorafenib (als Tosilat)

Australian public assessment report for Sorafenib › ... › files › auspar-sorafenib-140806.pdfAustralian Public Assessment Report for Sorafenib Proprietary Product Name: Nexavar

HIGHLIGHTS OF PRESCRIBING INFORMATION NEXAVAR … · HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXAVAR safely and effectively

Terapie sistemiche dell’epatocarcinoma (HCC): dalla ...amsdottorato.unibo.it/6586/2/MARINELLI_SARA_TESI.pdf · Il sorafenib (Nexavar; Bayer HealthCare Pharmaceuticals, Montville,

Nexavar® (sorafenib) w leczeniu miejscowo zaawansowanego ...bipold.aotm.gov.pl/assets/files/zlecenia_mz/2014/... · Nexavar® (sorafenib) w leczeniu miejscowo zaawansowanego lub